- Global Pharma News & Resources

In Vitro Fertilization Market exhibiting CAGR of 6.3% from 2023 to 2032, owing to growing acceptance of IVF procedures | insightSLICE

The global In Vitro Fertilization market size was estimated to be US$ 21.7 billion in 2021 and is expected grow at a CAGR of 6.3% between 2023 to 2032.

In the report on the In Vitro Fertilization (IVF) Industry, we discuss the trends and analyses of the global market with a prediction for 2022–2032. In addition to taking into account the competitive climate, the forecast study will contain a summary of the key players in the worldwide in vitro fertilization (IVF) market along with their market projections.

The report would also cover notable developments, regional and global sales subsidiaries, corporate strategies, R&D projects, staff size, and chief employees for all leading market participants.

Access the sample report:

For illustration, Laboratory Products & Services is the division that accounted for the majority of Thermo Fisher Scientific Inc.’s USD 24.4 billion in sales in 2018, according to the company’s business documentation.

The key players of the Global In Vitro Fertilization (IVF) Market are:

Global players involved in the in vitro fertilization (IVF) market include Progyny, Inc., The Cooper Companies, Inc., FUJIFILM Irvine Scientific, Genea Biomedx Pty Ltd, Cook Medical Incorporated, EMD Serono Inc., Bayer AG, Boston IVF, Ferring B.V., Merck & Co., Inc., OvaScience, Inc., Thermo Fisher Scientific, and Vitrolife.

Driving factors for the growth of Global In Vitro Fertilization (IVF) Market

The main factors influencing the worldwide in vitro fertilization market include the prevalence of infertility problems, polycystic ovarian syndrome (PCOS), dietary problems, and falling costs of IVF treatments. Over the past ten years, the infertility rate has considerably increased as a result of changing lifestyles.

The prevalence of physiological issues like endometriosis, issues with the uterus or fallopian tubes, poor egg quality, issues with ovulation, and the failure of the sperm to permeate and survive in the cervical mucus, as well as the existence of antibodies harming the sperms or eggs, negatively affects fertility rates.

This has facilitated the use of several forms of assisted reproduction technology (ART). Due to its high effectiveness, low cost, and reduced danger compared to other ARTs, in vitro fertilization has seen widespread adoption. Throughout the projection period, it is expected that the global in vitro fertilization (IVF) market would expand significantly.

Read more about the report inclusions:

Major statistics covered in this market:

With a target on prominent players in this industry, the research offers an in-depth analysis of significant companies with a significant market share global. It would define the company segment focused on in vitro fertilization (IVF) equipment, chemicals, and technologies.

Additionally, the market shares of well-known businesses operating in the global in vitro fertilization (IVF) market would indeed be calculated. Thermo Fisher Scientific Inc., for example, conducts operations via four divisions that are Life Sciences Solutions, Laboratory Products & Services, Specialty Diagnostics, and Analytical Instruments.

With a total revenue of US$9.52 billion in 2018, the firm’s Laboratory Products & Services business sector provides in vitro fertilization (IVF) products.

In vitro fertilization (IVF) equipment and reagent manufacturers’ business strategies, product portfolios, important developments, SWOT analyses, and R&D priorities are all taken into account in the study.

The analysis of the worldwide in vitro fertilization (IVF) market will also take into account the participants and their contributions to the market ecosystem. The company’s in vitro fertilization (IVF) commercial segment and product line would be the main emphasis.

Similar to this, part of the current development would concentrate on the most recent firm developments, including global expansion, mergers and acquisitions, the introduction of new products, and bilateral agreements and collaborations in the worldwide in vitro fertilization (IVF) market.

Related reports:

Global Transplant Diagnostics Market:

Global Pharmacovigilance Market:

Global In Vitro Fertilization (IVF) Market Key Segments:

By Product Type

  • Reagents
    • Media for embryo culture
    • Media for cryopreservation
    • Media for processing sperm
    • Media for processing ovum
  • Equipment
    • Cabinet
    • Ovum aspiration pump
    • Imaging system
    • Sperm separation system
    • Gas analyzer
    • Laser system
    • Incubators
    • Micromanipulation system
    • Accessories
    • Others

By Procedure Type

  • Fresh Donor
  • Frozen Donor
  • Fresh Non-donor
  • Frozen Non-donor

By End Use

  • Fertility Clinics
  • Hospitals & Others Setting

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of In Vitro Fertilization (IVF) Market

Due to its high incidence of infertility, higher incidence of the polycystic ovarian syndrome (PCOS), and prevalent lifestyle diseases, Asia Pacific provided the highest proportion to the worldwide in-vitro fertilization market in 2019.

Due to the rising number of specialized family planning clinics and surgical facilities, as well as the expansion of fertility tourism in important nations, the Asia Pacific in vitro fertilization market is predicted to have the quickest development over the forecast timeframe.

The in vitro fertilization industry in Europe accounts for a sizeable portion of the global market, and it is expected to continue to increase over the next years. Because of the increasing infertility rate within the region, North America is also expected to experience a significant increase during the projection period.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 28-Nov-2022